HLS Therapeutics Inc. announced that J. Spencer Lanthier and Don DeGolyer will not be standing for re-election to the HLS board of directors at HLS' upcoming annual meeting of shareholders to be held on June 16, 2023 (the "AGM"). Mr. Lanthier's and Mr. DeGolyer's terms as directors will expire at the conclusion of the AGM. The number of directors to be elected at the AGM will be reduced from ten to eight.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 CAD | +0.75% |
|
-2.47% | -15.19% |
07/06 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
28/05 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.19% | 77.82M | |
+26.15% | 75.76B | |
-2.46% | 23.95B | |
+14.23% | 8.7B | |
+1.47% | 8.29B | |
-32.92% | 6.7B | |
+17.70% | 5.38B | |
+1.31% | 4.08B | |
-9.24% | 3.79B | |
-10.20% | 3.3B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Hls Therapeutics Inc. Announces Resignation of Director